2026 Q1 Portfolio Activity
In 2026 Q1, PERCEPTIVE ADVISORS LLC maintained a portfolio of 136 distinct positions. The most significant new addition was MODERNA INC, now representing 0.99% of the total fund value. They heavily accumulated shares in CENTESSA PHARMACEUTICALS PLC, increasing the position by 80.2%. Conversely, PERCEPTIVE ADVISORS LLC completely exited their position in SPDR SERIES TRUST.
Position History
hover any row below to update
Loading…
Total Positions
136
Quarter
2026 Q1
Top Holding
PRAX (12.8%)
Top 10 Concentration
51.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 136
PERCEPTIVE ADVISORS LLC Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 12.83% | 10.49% |
#1
Prev: #1
|
6.5 | 40,000 | 2.0% |
P
S
|
2,035,986 | $655,974,329 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CELC
CELCUITY INC
|
Healthcare | 6.98% | 5.62% |
#2
Prev: #2
|
4.8 | -33,000 | -1.0% |
P
S
|
3,127,200 | $356,938,608 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 6.85% | 4.11% |
#3
1
Prev: #4
|
6.2 | 450,000 | 41.6% |
P
S
|
1,531,421 | $350,281,925 | 2015 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 4.49% | 3.09% |
#4
2
Prev: #6
|
2.8 | 300,000 | 3.8% |
P
S
|
8,285,461 | $229,507,270 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CNTA
CENTESSA PHARMA...
|
Healthcare | 4.09% | 1.30% |
#5
20
Prev: #25
|
5.1 | 2,341,269 | 80.2% |
P
S
|
5,258,903 | $208,883,627 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 4.04% | 4.86% |
#6
3
Prev: #3
|
2.1 | -172,596 | -6.8% |
P
S
|
2,373,795 | $206,448,951 | 2017 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 3.73% | 1.79% |
#7
8
Prev: #15
|
4.0 | 714,000 | 23.3% |
P
S
|
3,783,225 | $190,825,869 | 2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NUVL
NUVALENT INC
|
Healthcare | 3.17% | 2.99% |
#8
1
Prev: #7
|
1.8 | -84,600 | -5.1% |
P
S
|
1,580,505 | $161,922,737 | 2021 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 2.73% | 1.97% |
#9
4
Prev: #13
|
1.6 | -34,000 | -0.8% |
P
S
|
4,423,974 | $139,355,181 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PTGX
PROTAGONIST THE...
|
Healthcare | 2.54% | 2.10% |
#10
1
Prev: #11
|
1.5 | -119,546 | -8.9% |
P
S
|
1,230,879 | $129,734,647 | 2020 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
APGE
APOGEE THERAPEU...
|
Healthcare | 2.54% | 3.14% |
#11
6
Prev: #5
|
1.0 | -790,267 | -33.9% |
P
S
|
1,540,384 | $129,654,121 | 2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 2.41% | 2.91% |
#12
4
Prev: #8
|
1.5 | -135,629 | -3.2% |
P
S
|
4,142,551 | $123,075,190 | 2020 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AMLX
AMYLYX PHARMACE...
|
Healthcare | 2.25% | 1.78% |
#13
3
Prev: #16
|
1.9 | no change | no change |
P
S
|
8,284,882 | $115,159,860 | 2022 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IMTX
IMMATICS N.V
|
Healthcare | 2.00% | 1.94% |
#14
Prev: #14
|
1.8 | no change | no change |
P
S
|
10,383,456 | $102,173,207 | 2020 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RLAY
RELAY THERAPEUT...
|
Healthcare | 1.90% | 0.29% |
#15
55
Prev: #70
|
3.8 | 7,847,896 | 412.3% |
P
S
|
9,751,141 | $97,023,853 | 2020 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
INBX
INHIBRX BIOSCIE...
|
Healthcare | 1.90% | 2.05% |
#16
4
Prev: #12
|
1.3 | -10,000 | -0.7% |
P
S
|
1,442,707 | $96,993,192 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MGTX
MEIRAGTX HLDGS ...
|
Healthcare | 1.75% | 1.46% |
#17
6
Prev: #23
|
1.7 | no change | no change |
P
S
|
10,326,103 | $89,312,864 | 2018 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ZYME
ZYMEWORKS INC
|
Healthcare | 1.72% | 1.53% |
#18
3
Prev: #21
|
2.7 | 248,228 | 7.6% |
P
S
|
3,510,078 | $87,892,353 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SLDB
SOLID BIOSCIENC...
|
Healthcare | 1.68% | 1.19% |
#19
9
Prev: #28
|
1.2 | 73,107 | 0.6% |
P
S
|
11,906,646 | $85,727,851 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 1.66% | 1.21% |
#20
6
Prev: #26
|
3.2 | 1,189,895 | 34.2% |
P
S
|
4,668,839 | $84,646,051 | 2020 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BCRX
BIOCRYST PHARMA...
|
Healthcare | 1.38% | 0.44% |
#21
34
Prev: #55
|
3.6 | 4,271,504 | 135.1% |
P
S
|
7,434,033 | $70,771,994 | 2002 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ORKA
ORUKA THERAPEUT...
|
Healthcare | 1.34% | 0.80% |
#22
17
Prev: #39
|
1.0 | -81,000 | -5.5% |
P
S
|
1,395,501 | $68,449,324 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AORT
ARTIVION INC
|
Healthcare | 1.17% | 1.40% |
#23
1
Prev: #24
|
1.0 | -85,000 | -4.9% |
P
S
|
1,637,290 | $59,957,560 | 2016 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NRIX
NURIX THERAPEUT...
|
Healthcare | 1.13% | 1.20% |
#24
3
Prev: #27
|
1.0 | 155,000 | 4.4% |
P
S
|
3,710,877 | $57,518,594 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MRNA
PUT
MODERNA INC
|
PUT Option | 0.99% | — |
#25
Prev: #—
|
3.9 | 1,000,000 | — |
NEW
|
1,000,000 | $50,800,000 | 2020 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NAUT
NAUTILUS BIOTEC...
|
Healthcare | 0.96% | 0.44% |
#26
30
Prev: #56
|
1.4 | no change | no change |
P
S
|
12,594,211 | $48,865,538 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CTMX
CYTOMX THERAPEU...
|
Healthcare | 0.93% | 0.74% |
#27
13
Prev: #40
|
0.9 | 418,639 | 4.3% |
P
S
|
10,098,824 | $47,464,473 | 2015 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ANRO
ALTO NEUROSCIEN...
|
Healthcare | 0.88% | 0.57% |
#28
18
Prev: #46
|
2.4 | 225,500 | 12.6% |
P
S
|
2,009,893 | $45,182,395 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ENGN
ENGENE HOLDINGS...
|
Healthcare | 0.78% | 0.94% |
#29
3
Prev: #32
|
0.8 | -41,570 | -0.7% |
P
S
|
5,827,506 | $39,685,316 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 0.78% | 0.90% |
#30
4
Prev: #34
|
0.8 | -397,507 | -19.9% |
P
S
|
1,597,383 | $39,678,994 | 2020 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 0.77% | 0.89% |
#31
4
Prev: #35
|
0.8 | -2,500 | -2.8% |
P
S
|
85,419 | $39,377,305 | 2005 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 0.74% | — |
#32
Prev: #—
|
3.8 | 504,000 | — |
NEW
|
504,000 | $37,845,360 | 2003 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DAWN
DAY ONE BIOPHAR...
|
Healthcare | 0.74% | — |
#33
Prev: #—
|
3.8 | 1,755,799 | — |
NEW
|
1,755,799 | $37,644,331 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 0.72% | 1.10% |
#34
4
Prev: #30
|
0.3 | -129,459 | -28.2% |
P
S
|
328,884 | $36,621,233 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CRVS
CORVUS PHARMACE...
|
Healthcare | 0.66% | 0.10% |
#35
58
Prev: #93
|
3.3 | 1,600,000 | 231.1% |
P
S
|
2,292,441 | $33,538,412 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RGEN
REPLIGEN CORP
|
Healthcare | 0.65% | 0.92% |
#36
3
Prev: #33
|
0.8 | -35,000 | -11.1% |
P
S
|
280,541 | $33,053,341 | 2002 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
JAZZ
JAZZ PHARMACEUT...
|
Healthcare | 0.63% | 0.52% |
#37
11
Prev: #48
|
1.3 | no change | no change |
P
S
|
170,000 | $32,138,500 | 2012 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GLTO
DAMORA THERAPEU...
|
Healthcare | 0.62% | — |
#38
Prev: #—
|
3.7 | 1,223,000 | — |
NEW
|
1,223,000 | $31,675,700 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
XFOR
X4 PHARMACEUTIC...
|
Healthcare | 0.54% | 0.45% |
#39
15
Prev: #54
|
2.2 | 423,196 | 6.7% |
P
S
|
6,737,648 | $27,826,486 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GH
GUARDANT HEALTH...
|
Healthcare | 0.54% | 0.29% |
#40
28
Prev: #68
|
3.2 | 140,000 | 87.5% |
P
S
|
300,000 | $27,711,000 | 2019 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DRUG
BRIGHT MINDS BI...
|
Healthcare | 0.54% | 0.62% |
#41
3
Prev: #44
|
0.7 | -71,746 | -16.0% |
P
S
|
377,544 | $27,549,386 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IVVD
INVIVYD INC
|
Healthcare | 0.53% | 0.96% |
#42
11
Prev: #31
|
0.7 | -925,863 | -4.2% |
P
S
|
20,859,303 | $27,117,094 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SION
SIONNA THERAPEU...
|
Healthcare | 0.52% | 0.86% |
#43
7
Prev: #36
|
0.2 | -520,659 | -44.2% |
P
S
|
658,439 | $26,396,820 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 0.50% | 0.48% |
#44
8
Prev: #52
|
0.7 | 1,050 | 0.7% |
P
S
|
149,950 | $25,344,549 | 2019 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 0.49% | — |
#45
Prev: #—
|
3.7 | 258,600 | — |
NEW
|
258,600 | $25,148,850 | 2020 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SABS
SAB BIOTHERAPEU...
|
Healthcare | 0.48% | 0.05% |
#46
56
Prev: #102
|
3.2 | 5,628,533 | 700.8% |
P
S
|
6,431,743 | $24,633,576 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BLTE
BELITE BIO INC
|
Healthcare | 0.47% | 1.18% |
#47
18
Prev: #29
|
0.2 | -262,260 | -63.3% |
P
S
|
151,979 | $24,231,532 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TENX
TENAX THERAPEUT...
|
Healthcare | 0.45% | 0.10% |
#48
44
Prev: #92
|
3.2 | 1,008,640 | 229.7% |
P
S
|
1,447,782 | $23,150,034 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AXGN
AXOGEN INC
|
Healthcare | 0.45% | 0.46% |
#49
4
Prev: #53
|
0.7 | -86,828 | -11.1% |
P
S
|
697,312 | $23,101,947 | 2013 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 0.45% | 1.69% |
#50
32
Prev: #18
|
0.2 | -1,871,874 | -61.5% |
P
S
|
1,170,829 | $22,901,415 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-50 of 136 holdings